Easy to read patient leaflet for peginterferon alfa-2b. Includes indications, proper use, special instructions, precautions, and possible side effects.
Peginterferon alfa-2b injection is a synthetic (man-made) version of substances normally produced in the body to fight infection. Peginterferon alfa-2b ...
Pegylated interferon alfa-2b is a treatment for hepatitis C developed by Schering-Plough, brand name is PegIntron. It was approved in January 2001.
Peginterferon alfa-2a is superior to peginterferon alfa-2b in the treatment of naive patients with hepatitis C virus infection: meta-analysis of randomized controlled ...
Peginterferon alfa-2b may cause or worsen the following conditions that may be serious or cause death: infections; mental illness including depression ...
Use in Cancer. Peginterferon alfa-2b is approved to treat: Melanoma. It is used as adjuvant therapy in patients who have had surgery to remove cancer that has ...
These highlights do not include all the information needed to use PEGINTRON safely and effectively. See full prescribing information for PEGINTRON.
What is peginterferon alfa-2b? Peginterferon alfa-2b is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment ...
On March 29, 2011, the U. S. Food and Drug Administration approved peginterferon alfa-2b (Sylatron, Schering Corporation, Kenilworth, NJ 07033), for the ...
Peginterferon alfa-2b is made from human proteins that help the body fight viral infections. Peginterferon alfa-2b is used to treat chronic hepatitis C in adults.